Trademark Overview
On Friday, February 23, 2024, a trademark application was filed for KAPRAIMA with the United States Patent and Trademark Office. The USPTO has given the KAPRAIMA trademark a serial number of 98418315. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, September 7, 2024. This trademark is owned by Immunocore Limited. The KAPRAIMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers